Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions

HIV Envelope Protein gp41

  • Vaccines and Antiviral Agents
    HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces gp41 Antibody Immunodominance in Rhesus Macaques
    Qifeng Han, Wilton B. Williams, Kevin O. Saunders, Kelly E. Seaton, Kevin J. Wiehe, Nathan Vandergrift, Tarra A. Von Holle, Ashley M. Trama, Robert J. Parks, Kan Luo, Thaddeus C. Gurley, Thomas B. Kepler, Dawn J. Marshall, David C. Montefiori, Laura L. Sutherland, Munir S. Alam, John F. Whitesides, Cindy M. Bowman, Sallie R. Permar, Barney S. Graham, John R. Mascola, Patrick C. Seed, Koen K. A. Van Rompay, Georgia D. Tomaras, M. Anthony Moody, Barton F. Haynes
  • Vaccines and Antiviral Agents
    Enfuvirtide (T20)-Based Lipopeptide Is a Potent HIV-1 Cell Fusion Inhibitor: Implications for Viral Entry and Inhibition
    Xiaohui Ding, Xiujuan Zhang, Huihui Chong, Yuanmei Zhu, Huamian Wei, Xiyuan Wu, Jinsheng He, Xinquan Wang, Yuxian He
  • Structure and Assembly
    Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer
    Yuhang Liu, Junhua Pan, Yongfei Cai, Nikolaus Grigorieff, Stephen C. Harrison, Bing Chen
  • Free
    Commentary
    New Connections: Cell-to-Cell HIV-1 Transmission, Resistance to Broadly Neutralizing Antibodies, and an Envelope Sorting Motif
    S. Abigail Smith, Cynthia A. Derdeyn
  • Vaccines and Antiviral Agents
    Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers
    Eden P. Go, Haitao Ding, Shijian Zhang, Rajesh P. Ringe, Nathan Nicely, David Hua, Robert T. Steinbock, Michael Golabek, James Alin, S. Munir Alam, Albert Cupo, Barton F. Haynes, John C. Kappes, John P. Moore, Joseph G. Sodroski, Heather Desaire
  • Pathogenesis and Immunity
    Monoclonal Antibodies Specific for the V2, V3, CD4-Binding Site, and gp41 of HIV-1 Mediate Phagocytosis in a Dose-Dependent Manner
    Thomas Musich, Liuzhe Li, Lily Liu, Susan Zolla-Pazner, Marjorie Robert-Guroff, Miroslaw K. Gorny
  • Vaccines and Antiviral Agents
    Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies
    Timothée Bruel, Florence Guivel-Benhassine, Valérie Lorin, Hugues Lortat-Jacob, Françoise Baleux, Katia Bourdic, Nicolas Noël, Olivier Lambotte, Hugo Mouquet, Olivier Schwartz
  • Pathogenesis and Immunity
    Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors
    Beatriz Pacheco, Nirmin Alsahafi, Olfa Debbeche, Jérémie Prévost, Shilei Ding, Jean-Philippe Chapleau, Alon Herschhorn, Navid Madani, Amy Princiotto, Bruno Melillo, Christopher Gu, Xin Zeng, Youdong Mao, Amos B. Smith, Joseph Sodroski, Andrés Finzi
  • Vaccines and Antiviral Agents
    A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus
    Shengwen Xiong, Pedro Borrego, Xiaohui Ding, Yuanmei Zhu, Andreia Martins, Huihui Chong, Nuno Taveira, Yuxian He
  • Vaccines and Antiviral Agents
    Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors
    Shan Su, Yun Zhu, Sheng Ye, Qianqian Qi, Shuai Xia, Zhenxuan Ma, Fei Yu, Qian Wang, Rongguang Zhang, Shibo Jiang, Lu Lu

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 15
Back to top

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514